Adicet Bio, Inc. Share Price

NASDAQ: ACET

Small Cap

$0.80

-0.01

(-0.91%)

as on September 16, 2025 at 1:29 am IST

$₹

Adicet Bio, Inc. Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$0.77
Day's Price Range
$0.82
$0.8
3.75%
Downside
2.50%
Upside
52 Week's Low
52 Week's High
$0.45
52-Week Price Range
$1.57
$0.8
44.11%
Downside
96.25%
Upside

Adicet Bio, Inc. share price movements today

Previous Close: $0.81
Open: $0.81
Volume: 440.6K
Day's Low - High: $0.77 - $0.82
52 Week Low - High: $0.45 - $1.57

Adicet Bio, Inc. Historical Returns

1 Month Return: + 23.69 %
3 Month Return: + 7.98 %
1 Year Return: -45.62 %
3 Year Return: -95.27 %
5 Year Return: -64.46 %

Adicet Bio, Inc. Stock Fundamentals & Key Indicators

Check Adicet Bio, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$67.5M

EPS (TTM)

-1.2317

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

0.82

EBITDA

-119.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

1298900.00%

Adicet Bio, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adicet Bio, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Adicet Bio, Inc.	BUY	$67.5M	-64.46%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Adicet Bio, Inc. Stock including INR - Dollar returns

The Adicet Bio, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Adicet Bio, Inc. investment value today

Current value as on today

₹58,677

Returns

₹41,323

(-41.32%)

Returns from Adicet Bio, Inc. Stock

₹46,309 (-46.31%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Adicet Bio, Inc. Stock

Based on 15 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 15 analysts, 80% of analysts recommend a 'BUY' rating for Adicet Bio, Inc.. Average target price of $5.6

Adicet Bio, Inc. Share Price Target

Get share price movements and forecasts by analysts on Adicet Bio, Inc..

What analysts predicted

85.71%UPSIDE

Target Price

$5.6

Current Price

$0.8

Analyzed by

15 Analysts

Target

$5.60

Adicet Bio, Inc. target price $5.6, a slight upside of 85.71% compared to current price of $0.8. According to 15 analysts rating.

Adicet Bio, Inc. Stock's Interest Amongst Investors

Search interest for Adicet Bio, Inc. Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:7% versus previous 30 day period

Adicet Bio, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	12	-	-	-	6	-	-
Gross Profit	-1	-2	-2	11	-1	-1	-1	3	-1	-1
Operating Income	-33	-34	-52	-31	-30	-32	-33	-30	-29	-32
EBITDA	-29	-30	-47	-27	-26	-28	-28	-27	-29	-32
Interest Expense	0	0	0	0	0	-	0	0	-	-
Depreciation	1	1	1	1	1	1	1	1	1	1
Income Before Tax	-30	-32	-49	-29	-28	-29	-30	-28	-28	-31
Income Tax Expense	-1	0	0	1	1	-1	-	-	-	-
Net Income	-29	-32	-49	-29	-28	-29	-30	-28	-28	-31
Net Profit Margin	0.00%	0.00%	0.00%	-228.70%	0.00%	0.00%	0.00%	-441.55%	0.00%	0.00%

Adicet Bio, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Jun 2020	Dec 2020	Jun 2021	Dec 2021	Jun 2022	Dec 2022	Jun 2023	Dec 2023	Dec 2024
Total Revenue	0	0	17	17	9	9	24	24	-	-
Gross Profit	0	-	17	-	9	-	24	-	-6	-6
Operating Income	-31	-	-39	-	-61	-	-72	-	-152	-127
EBITDA	-26	-	-37	-	-60	-	-64	-	-136	-110
Interest Expense	-	-	0	-	0	-	0	-	0	0
Depreciation	-	-	1	-	1	-	2	-	6	6
Income Before Tax	-28	-	-39	-	-62	-	-69	-	-142	-117
Income Tax Expense	0	-	-2	-	0	-	-2	-	5	-
Net Income	-28	-28	-36	-36	-61	-61	-69	-67	-142	-117
Net Profit Margin	-2827.94%	-2827.94%	-204.87%	-204.87%	-637.19%	-637.19%	-279.27%	-268.22%	0.00%	0.00%

Adicet Bio, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-32	-49	-29	-28	-29	-30	-28	-28	-31
Operating Cash Flow	-24	-21	-23	-22	-23	-22	-24	-25	-26
Investing Cash Flow	-1	0	0	0	0	-96	-22	-2	32
Financing Cash Flow	0	0	0	110	0	0	0	0	0
Change in Cash	-26	-22	-23	87	-23	-118	-46	-28	6

Adicet Bio, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	33	-33	-9	-28	-36	-61	-69	-142	-117
Operating Cash Flow	8	-11	-18	-27	-41	-51	-44	-93	-92
Investing Cash Flow	-8	0	-16	-47	115	-2	-16	-4	-119
Financing Cash Flow	-8	64	11	76	0	242	41	0	111
Change in Cash	-8	30	-23	1	73	188	-20	-97	-100

Global Institutional Holdings in Adicet Bio, Inc.

Funds	Holdings
Orbimed Advisors, LLC	13.84%
TANG CAPITAL MANAGEMENT LLC	9.94%
RA Capital Management, LLC	9.12%
Goldman Sachs Group Inc	4.61%
Vanguard Group Inc	3.88%

See all

Insights on Adicet Bio, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, ACET stock has moved up by 23.7%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 121.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 218.8%

About Adicet Bio, Inc.

adicet bio, inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies with initial focus on cancer. adicet is developing novel universal immune cell therapies based on gamma delta t cells engineered with chimeric antigen receptors (cars) or t cell receptors (tcrs). adicet is also focused on identifying and validating cancer specific targets directed to the intracellular proteome and generating tcr-like mabs (tcrls) directed to these cancer-specific peptide targets presented by mhc class i complexes. these tcrls can be used to arm t cells, as t cell engagers or as antibody drug conjugates (adc). in august 2016, adicet entered a strategic collaboration with regeneron pharmaceuticals, inc. to develop next-generation engineered immune-cell therapeutics using adicet’s gamma delta t cell allogeneic platform technology. adicet bio raised $51m in series a financing led by orbimed partners, orbimed israel, novartis v

Organisation	Adicet Bio, Inc.
Headquarters	131 Dartmouth Street, Boston, MA, United States, 02116
Industry	Distribution Services
CEO	Mr. Chen Schor BA, CPA, M.B.A.
E-voting on shares	Click here to vote

Key Management of Adicet Bio, Inc.

Name	Title
Mr. Chen Schor BA, CPA, M.B.A.	CEO, President & Director
Mr. Brian Nicholas Harvey	Chief Financial Officer
Dr. Blake Aftab Ph.D.	Senior VP & Chief Scientific Officer
Dr. Donald Healey Ph.D.	Chief Technology Officer
Ms. Amy Locke	Chief Human Resource Officer
Dr. Julie Maltzman M.D.	Chief Medical Officer

FAQs

What is Adicet Bio, Inc. share price today?

Adicet Bio, Inc. share price today is $0.8 as on September 16, 2025 at 1:29 am IST at the close of the market. Adicet Bio, Inc. share today touched a day high of $0.82 and a low of $0.77.

What is the 52 week high and 52 week low for Adicet Bio, Inc. share?

Adicet Bio, Inc. share touched a 52 week high of $1.57 on September 19, 2024 and a 52 week low of $0.45 on April 10, 2025. Adicet Bio, Inc. stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $0.8,which is 49.04% down from its 52 week high and 78.93% up from its 52 week low.

What is Adicet Bio, Inc.'s market capitalisation today?

Adicet Bio, Inc. market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Adicet Bio, Inc. Stock (ACET) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Adicet Bio, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adicet Bio, Inc. Shares that will get you 1.8750 shares as per Adicet Bio, Inc. share price of $0.8 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Adicet Bio, Inc. Stock (ACET) from India?

Indian investors can start investing in Adicet Bio, Inc. (ACET) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 3:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Adicet Bio, Inc. stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 3:43 am IST). Based on Adicet Bio, Inc. share’s latest price of $0.8 as on September 16, 2025 at 1:29 am IST, you will get 12.5000 shares of Adicet Bio, Inc.. Learn more about fractional shares .

What are the returns that Adicet Bio, Inc. has given to Indian investors in the last 5 years?

Adicet Bio, Inc. stock has given -64.46% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?